1. Home
  2. CRGX vs WASH Comparison

CRGX vs WASH Comparison

Compare CRGX & WASH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CRGX
  • WASH
  • Stock Information
  • Founded
  • CRGX 2021
  • WASH 1800
  • Country
  • CRGX United States
  • WASH United States
  • Employees
  • CRGX N/A
  • WASH N/A
  • Industry
  • CRGX
  • WASH Major Banks
  • Sector
  • CRGX
  • WASH Finance
  • Exchange
  • CRGX Nasdaq
  • WASH Nasdaq
  • Market Cap
  • CRGX 190.0M
  • WASH 542.9M
  • IPO Year
  • CRGX 2023
  • WASH N/A
  • Fundamental
  • Price
  • CRGX $4.46
  • WASH $29.65
  • Analyst Decision
  • CRGX Hold
  • WASH Buy
  • Analyst Count
  • CRGX 7
  • WASH 4
  • Target Price
  • CRGX $4.67
  • WASH $32.25
  • AVG Volume (30 Days)
  • CRGX 502.9K
  • WASH 146.9K
  • Earning Date
  • CRGX 08-11-2025
  • WASH 07-21-2025
  • Dividend Yield
  • CRGX N/A
  • WASH 7.55%
  • EPS Growth
  • CRGX N/A
  • WASH N/A
  • EPS
  • CRGX N/A
  • WASH N/A
  • Revenue
  • CRGX N/A
  • WASH $110,088,000.00
  • Revenue This Year
  • CRGX $57.81
  • WASH $57.46
  • Revenue Next Year
  • CRGX N/A
  • WASH $9.82
  • P/E Ratio
  • CRGX N/A
  • WASH N/A
  • Revenue Growth
  • CRGX N/A
  • WASH N/A
  • 52 Week Low
  • CRGX $3.00
  • WASH $24.95
  • 52 Week High
  • CRGX $25.45
  • WASH $40.59
  • Technical
  • Relative Strength Index (RSI)
  • CRGX 57.89
  • WASH 67.16
  • Support Level
  • CRGX $4.09
  • WASH $27.43
  • Resistance Level
  • CRGX $4.51
  • WASH $28.25
  • Average True Range (ATR)
  • CRGX 0.18
  • WASH 0.68
  • MACD
  • CRGX 0.00
  • WASH 0.27
  • Stochastic Oscillator
  • CRGX 77.18
  • WASH 93.29

About CRGX CARGO Therapeutics Inc.

Cargo Therapeutics Inc is a clinical-stage biotechnology company positioned to advance next generation, potentially curative cell therapies for cancer patients. It programs, platforms, and manufacturing are designed to directly address the limitations of approved chimeric antigen receptor (CAR) T-cell therapies. Its product includes CRG-023, an investigational tri-specific CAR T designed to address several known causes of relapse associated with existing CAR T-cell therapies such as loss of tumor antigen expression, loss of co-stimulation (e.g., via CD58/CD2 signaling) and T cell exhaustion. CRG-023 is designed to target the B-cell lineage antigens (CD19, CD20, CD22) via tri-cistronic expression of three distinct CARs from a single lentiviral vector.

About WASH Washington Trust Bancorp Inc.

Washington Trust Bancorp Inc through its subsidiaries offers banking and financial services to individuals and businesses. It offers a full range of financial services, including commercial banking, mortgage banking, personal banking, and wealth management and trust services, through its offices located in Rhode Island, Connecticut, and Massachusetts. It operates in two segments. The Commercial Banking segment includes lending activities, commercial loans, residential real estate loan deposit activities, and others. The Wealth Management Services segment consists of investment management, financial planning, personal trust, and estate services including services as trustee, personal representative, custodian and guardian, and settlement of decedents' estates.

Share on Social Networks: